Busulfan & Melphalan Conditioning for Autologous Stem Cell Transplant (ASCT) and Lenalidomide Maintenance

Clinical trial NCT01702831 · COMPLETED

Trial details

NCT number: NCT01702831
Sponsor: University Health Network, Toronto
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2013-10-01
Primary completion: 2022-07-31
Enrollment: 78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.